Log in to WRAL.com with one click using your favorite social network:
OR
Log in using your WRAL.com account:



Wrong email/password combination.

Forgot password?

Register with WRAL.com using your favorite social network:
OR
Register for a WRAL.com account using our web form.

11:36 a.m. • 5-22-13

Weather Forecast for Raleigh

  • Today: Thunderstorm.
    • Hi: 86° F
  • Thu: Thunderstorm.
    • Hi: 83° F
  • Fri: Partly Cloudy.
    • Hi: 76° F

Other Locations

> 7 Day Forecast

Doppler Image

Alert

  • Breaking News:  The fate of Mario Andrette McNeill, who is accused of raping and killing 5-year-old Shaniya Davis in 2009, is in the hands of a jury following closing arguments Wednesday morning. If the eight-man, four-woman jury finds him guilty, they would then hear evidence before deciding whether to sentence him to life in prison without parole or death.

Published: 2008-12-17 17:40:00
Updated: 2008-12-17 18:24:27

Researchers use colon tumors' genes to predict recurrence


Researchers study genetic expression in colon tumors
Researchers study genetic expression in colon tumors
print friendly

Duke researchers now have a model for predicting the risk that early stage colon cancer will recur. It may also be used to predict a patient’s sensitivity to different types of chemotherapy.

Though the model isn’t in clinical trials yet, researchers hope it may one day help patients beat the odds as they fight cancer.

Frank Walters, 55, of Lynchburg, Va., learned three months ago that he had stage three colon cancer.

“It was close to penetrating the colon wall, but it hadn't penetrated yet,” Walters said.

Walters had surgery to remove the tumor, but then started fighting the odds of the cancer returning.

Dr. David Hsu, a Duke University Medical Center oncologist, said that without chemotherapy, the recurrence risk is as high as 60 percent.

Though Walters is receiving chemotherapy, his risk of recurrence is still as high as 20 percent.

“We need to do a better job of figuring out what a better treatment for these patients is,” Hsu said.

Dr. Katherine Garman, a Duke gastroenterology fellow, is leading a study looking at the genetic expression of colon tumor samples. She has found patterns that place some patients at a higher risk.

“For the patients who are likely to have recurrence, (we can) actually choose specific therapy that we think will be most effective for them,” Garman said.

Hsu said “specific proteins and pathways” are important in how a tumor grows and develops.

The research also could lead to newer drugs tailored to specific tumor types, Garman said.

Duke researchers are also looking at the genetic makeup of tumors in breast cancer.


0 Comments


WRAL.com welcomes your comments on this story. All comments are moderated prior to publication based on our posting guidelines. Please review them prior to posting and if your message is not approved.

View Comments 0 COMMENTS

This story is closed for comments.

View Comments 0 COMMENTS